Antimicrobial stewardship forum wallis suite all nations centre cardiff
Download
1 / 8

Antimicrobial Stewardship Forum Wallis Suite, All Nations Centre, Cardiff - PowerPoint PPT Presentation


  • 124 Views
  • Uploaded on

Antimicrobial Stewardship Forum Wallis Suite, All Nations Centre, Cardiff. 3 rd May 2012. Robin A Howe. 20 th August 2010, Paul Williams, Director General of Health & Social Services.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Antimicrobial Stewardship Forum Wallis Suite, All Nations Centre, Cardiff' - deanna-levine


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Antimicrobial stewardship forum wallis suite all nations centre cardiff
Antimicrobial Stewardship ForumWallis Suite,All Nations Centre,Cardiff

3rd May 2012

Robin A Howe

Antimicrobial use in Primary Care


20 th august 2010 paul williams director general of health social services
20th August 2010, Paul Williams,Director General of Health & Social Services

  • To reduce the incidence of Clostridium difficileinfectionand the risk of increasing antimicrobial resistance in existing and emerging pathogens Medical Directors agreed that an all Wales approach to antimicrobial prescribing should be adopted. Public Health Wales has been tasked with developing an evidence based policy and protocols to facilitate this approach. Effective implementation will be dependent on the full engagement of medical directors, prescribing clinicians, local antimicrobial pharmacists, primary care colleagues and support from Public Health Wales”.


Progress
Progress

  • Agreement from Joint Medical Directors Group

  • Endorsement from DARHAI (Decontamination, Antimicrobial Resistance, and Healthcare-Associated Infection Group) for establishment of an Antimicrobial Guideline Development Group

    • Partnership between Public Health Wales & Welsh Medicines Partnership


  • Proposed membership for AGDG)

    • 4 consultant microbiologists (with representation across Wales)

    • 4 antimicrobial pharmacists (with representation across Wales)

    • GPC Wales representative (with prescribing interest in antimicrobials)

    • Chair of the All Wales Prescribing Advisory Group

    • 3 representatives of the PHW Antimicrobial Resistance Programme

    • 1 representative of the Welsh Medicines Partnership

  • Likely support agreed

    • 0.2 wte WMP

    • 0.2 wte PHW



Session 1: Formularies & Guidance (10.20 - 13:00)

Chairperson: Karen Fitzgerald

10.20 Guest Speaker

Developing HPA guidance for the management of infection in Primary Care

Cliodna McNulty (HPAPrimary Care Unit)

10.40 Primary Care guidance in Wales

Lorna McFarlane (Public Health Wales)

11:00 Discussion and coffee break

11.40 Supporting good prescribing practice in Primary Care

Cliodna McNulty

12.00 ATTRACT – a system that provides rapid evidence based summaries to

clinical questions

Jon Brassey (TRIP, Public Health Wales)

12.20 Injectable Medicines Guide and formularies update

Robin Burfield (NWIS)

12:40 An update on the standard prescription chart for Wales

Bob McArtney (Pharmacy, UHW)

13.00 LUNCH


Session 2: ECDC Point Prevalence Survey (13.40 - 15.45)

Chairperson: Dafydd Williams

13:40 E-learning programme: HCAI update and antibiotic prescribing option

Neil Wigglesworth (WHAIP, Public Health Wales)

14:00 PPS of HAI and Medical Device Usage 2011

Eleri Davies (WHAIP, Public Health Wales)

14.30 PPS of Antimicrobial Usage 2011

Robin Howe (ARP, Public Health Wales)

15.20 Discussion and Closing remarks


ad